Assessment of Electroencephalographic Changes in Different Stages of Chronic Kidney Disease

Faculty Medicine Year: 2022
Type of Publication: ZU Hosted Pages:
Authors:
Journal: The Egyptian Journal of Hospital Medicine Faculty of Medicine Ain Shams University Volume:
Keywords : Assessment , Electroencephalographic Changes , Different Stages , Chronic    
Abstract:
Background: Chronic Kidney Disease (CKD) is defined by the Kidney Disease Outcomes Quality Initiative (KDOQI) working group of the National Kidney Foundation (NKF) as evidence of structural or functional kidney abnormalities that persist for at least 3 months, with or without a decreased Glomerular Filtration Rate (GFR). Electroencephalogram (EEG) is useful in assessing patients in uremic encephalopathy and in monitoring their progress. Objective: The aim of the current study was ro evaluate the EEG changes in different stages of CKD. Patients and methods: This cross-sectional study was conducted in the Pediatrics Department at Zagazig University Hospitals on 61 patients with CKD at different stages. All included patients had been subjected to predesigned working sheet. Serum creatinine level, 24-hour urinary protein excretion, estimation of glomerular filtration rate and EEG were done for all patients. GFR was calculated by MDRD formula. Results: Our study showed statistically significant increased asymmetry and dysrhythmia among stages 3 and 4 than stages 1 and 2, while symmetry was statistically significant higher among stages 1 and 2 than stages 3 and 4. There was statistically significant increased low amplitude among stages 3 and 4 than stages 1 and 2, while high amplitude was higher among stages 1 and 2 than stages 3 and 4, with no significant difference between the pre-dialytic stages regarding medium and high amplitudes. There was highly statistically significant difference between the CKD patients with and without neuropathy regarding albumin, creatinine and eGFR where albumin and creatinine was higher among uremic neuropathy patients than non-uremic neuropathy, while eGFR was highly significantly higher among the non-uremic neuropathy than the uremic neuropathy patients. Conclusion: EEG findings which are characteristics of uremic encephalopathy can be present in CKD patients without frank signs of encephalopathy.
   
     
 
       

Author Related Publications

  • Sabry Abdel Rahman Tolba Abdel Haleem Elshobary, "Bedside Sonographic Assessments of IVC Collapsibility Index in Children on Hemodialysis", Wolters Kluwer Health, 2022 More
  • Sabry Abdel Rahman Tolba Abdel Haleem Elshobary, "Prevalence of Psychiatric Disorders in Children with Chronic Kidney Disease in Zagazig University Hospitals", Faculty of medicine, Ain Shams university, 2020 More
  • Sabry Abdel Rahman Tolba Abdel Haleem Elshobary, "Hepatitis B Immunization Status in Children with Chronic Kidney Disease: Experience at a Single Center, Egypt", MDPI, 2023 More
  • Sabry Abdel Rahman Tolba Abdel Haleem Elshobary, "Therapeutic Plasma Exchange; One Year Single Center Experience", The Egyptian Society of Pediatric Nephrology and Transplantation (ESPNT), 2020 More
  • Sabry Abdel Rahman Tolba Abdel Haleem Elshobary, "Brachial artery flow-mediated dilatation and carotid intima-media thickness in children with idiopathic nephrotic syndrome", Iranian society of Nephrology, 2018 More

Department Related Publications

  • Marwa Zakaria Mohammed Mustafa, "Cluster of differentiation 97 as a biomarker for the detection of minimal residual disease in common acute lymphoblastic leukemia", Wolters Kluwer - Medknow, 2017 More
  • Dina Tawfeek Mohammed El Hoseny Sarhan, "Serum and CSF adiponectin, Leptin and Interleukin 6 levels as adipocytokines in Egyptien children with febrile sezures: Cross sectional study.", Pubmed, 2016 More
  • Nihad Ahmed Karam AbdelFattah, "Impact of iron deficiency anemia on the function of the immune system in children", Medicine®, 2016 More
  • Rabab Mohamed Abdelhamid Elbehidy, "MicroRNA-21 as a novel biomarker in diagnosis and response to therapy in asthmatic children.", MicroRNA-21 as a novel biomarker in diagnosis and response to therapy in asthmatic children., 2016 More
  • Doaa Youssef Mohamed, "MicroRNA-21 as a novel biomarker in diagnosis and response to therapy in asthmatic children.", MicroRNA-21 as a novel biomarker in diagnosis and response to therapy in asthmatic children., 2016 More
Tweet